GEMINI THERAPEUTICS INC
Q3 2022 13F Holders
CUSIP
36870G105
Type
Equity
Class
COM
Num filings
50
Total reported value, excl. options
$43.9 M
Compare 2022 Q3 to
2022 Q4
2022 Q2
2022 Q1
2021 Q4
2021 Q3
2021 Q2
2021 Q1
Manager
Report Date
Value ($000)
Shares
Option Type